• Je něco špatně v tomto záznamu ?

Effects of synthetic cathinone naphyrone in the conditioned place preference test - Evidence of its addictive potential

H. Danda, N. Pinterová-Leca, K. Šíchová, K. Štefková-Mazochová, K. Syrová, L. Olejníková, M. Končická, V. Mazoch, E. Lhotková, M. Kuchař, T. Páleníček

. 2022 ; 421 (-) : 113713. [pub] 20211211

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22010771

Naphyrone, also known as NRG-1, is a novel psychoactive substance (NPS), a cathinone with stimulatory properties available on the grey/illicit drug market for almost a decade. It is structurally related to infamously known powerful stimulants with the pyrovalerone structure, such as alpha-pyrrolidinovalerophenone (α-PVP) or methylenedioxypyrovalerone (MDPV) that are labeled as a cheap replacement for cocaine and other stimulants. Despite the known addictive potential of α-PVP and MDPV, there are no studies directly evaluating naphyrone's addictive potential e.g., in conditioned place preference (CPP) test or using self-administration. Therefore, our study was designed to evaluate the addictive potential in a CPP test in male Wistar rats and compare its effect to another powerful stimulant with a high addictive potential - methamphetamine. Naphyrone increased time spent in the drug-paired compartment with 5 and 20 mg/kg s.c. being significant and 10 mg/kg s.c. reaching the threshold (p = 0.07); the effect was comparable to that of methamphetamine 1.5 mg/kg s.c. The lowest dose, naphyrone 1 mg/kg s.c., had no effect on CPP. Interestingly, no dose response effect was detected. Based on these data, we are able to conclude that naphyrone has an addictive potential and may possess a significant risk to users.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010771
003      
CZ-PrNML
005      
20231213104810.0
007      
ta
008      
220425s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bbr.2021.113713 $2 doi
035    __
$a (PubMed)34906607
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Danda, Hynek, $d 1988- $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic $7 xx0311507
245    10
$a Effects of synthetic cathinone naphyrone in the conditioned place preference test - Evidence of its addictive potential / $c H. Danda, N. Pinterová-Leca, K. Šíchová, K. Štefková-Mazochová, K. Syrová, L. Olejníková, M. Končická, V. Mazoch, E. Lhotková, M. Kuchař, T. Páleníček
520    9_
$a Naphyrone, also known as NRG-1, is a novel psychoactive substance (NPS), a cathinone with stimulatory properties available on the grey/illicit drug market for almost a decade. It is structurally related to infamously known powerful stimulants with the pyrovalerone structure, such as alpha-pyrrolidinovalerophenone (α-PVP) or methylenedioxypyrovalerone (MDPV) that are labeled as a cheap replacement for cocaine and other stimulants. Despite the known addictive potential of α-PVP and MDPV, there are no studies directly evaluating naphyrone's addictive potential e.g., in conditioned place preference (CPP) test or using self-administration. Therefore, our study was designed to evaluate the addictive potential in a CPP test in male Wistar rats and compare its effect to another powerful stimulant with a high addictive potential - methamphetamine. Naphyrone increased time spent in the drug-paired compartment with 5 and 20 mg/kg s.c. being significant and 10 mg/kg s.c. reaching the threshold (p = 0.07); the effect was comparable to that of methamphetamine 1.5 mg/kg s.c. The lowest dose, naphyrone 1 mg/kg s.c., had no effect on CPP. Interestingly, no dose response effect was detected. Based on these data, we are able to conclude that naphyrone has an addictive potential and may possess a significant risk to users.
650    _2
$a alkaloidy $x farmakologie $7 D000470
650    _2
$a zvířata $7 D000818
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a stimulanty centrálního nervového systému $x aplikace a dávkování $x farmakologie $7 D000697
650    _2
$a klasické podmiňování $x účinky léků $7 D003214
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methamfetamin $x aplikace a dávkování $x farmakologie $7 D008694
650    _2
$a pentanony $x aplikace a dávkování $x farmakologie $7 D010422
650    _2
$a pyrrolidiny $x aplikace a dávkování $x farmakologie $7 D011759
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    12
$a poruchy spojené s užíváním psychoaktivních látek $7 D019966
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pinterová-Leca, Nikola $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic
700    1_
$a Šíchová, Klára $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
700    1_
$a Štefková-Mazochová, Kristýna $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
700    1_
$a Syrová, Kateřina $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic
700    1_
$a Olejníková, Lucie $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
700    1_
$a Končická, Markéta $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
700    1_
$a Mazoch, Vladimír $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
700    1_
$a Lhotková, Eva $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic
700    1_
$a Kuchař, Martin $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Technická 5, Prague 6 166 28, Czech Republic
700    1_
$a Páleníček, Tomáš $u National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic. Electronic address: tomas.palenicek@nudz.cz
773    0_
$w MED00000660 $t Behavioural brain research $x 1872-7549 $g Roč. 421, č. - (2022), s. 113713
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34906607 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20231213104806 $b ABA008
999    __
$a ok $b bmc $g 1788748 $s 1161969
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 421 $c - $d 113713 $e 20211211 $i 1872-7549 $m Behavioural brain research $n Behav Brain Res $x MED00000660
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...